Dissolution and precipitation behavior of ternary solid dispersions of ezetimibe in biorelevant media

References

• Gao P, Shi Y. Characterization of supersaturatable formulations for improved absorption of poorly soluble drugs. AAPS J 2012;14:703–13.
   PubMed Web of Science ®Google Scholar
• Bevernage J, Brouwers J, Clarysse S, et al. Drug supersaturation in simulated and human intestinal fluids representing different nutritional states. J Pharm Sci 2010;99:4525–34.
   PubMed Web of Science ®Google Scholar
• Brouwers J, Brewster ME, Augustijns P. Supersaturating drug delivery systems: the answer to solubility‐limited oral bioavailability? J Pharm Sci 2009;98:2549–72.
   PubMed Web of Science ®Google Scholar
• Dahan A, Beig A, Ioffe-Dahan V, et al. The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: Increased apparent solubility and drug flux through the intestinal membrane. AAPS J 2013;15:347–53.
   PubMed Web of Science ®Google Scholar
• Janssens S, Nagels S, De Armas HN, et al. Formulation and characterization of ternary solid dispersions made up of itraconazole and two excipients, TPGS 1000 and PVPVA 64 that were selected based on a supersaturation screening study. Eur J Pharm Biopharm 2008;69:158–66.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60.
   PubMed Web of Science ®Google Scholar
• Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech 2006;7:87–92.
   PubMed Web of Science ®Google Scholar
• Brewster M, Vandecruys R, Verreck G, et al. Supersaturating drug delivery systems: effect of hydrophilic cyclodextrins and other excipients on the formation and stabilization of supersaturated drug solutions. Pharmazie 2008;63:217–20.
   PubMed Web of Science ®Google Scholar
• Bevernage J, Hens B, Brouwers J, et al. Supersaturation in human gastric fluids. Eur J Pharm Biopharm 2012;81:184–9.
   PubMed Web of Science ®Google Scholar
• Vandecruys R, Peeters J, Verreck G, et al. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design. Int J Pharm 2007;342:168–75.
   PubMed Web of Science ®Google Scholar
• Shah TJ, Amin AF, Parikh JR, et al. Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug. AAPS PharmSciTech 2007;8:E18–24.
   Web of Science ®Google Scholar
• Goddeeris C, Willems T, Van den Mooter G. Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781. Eur J Pharm Sci 2008;34:293–302.
   PubMed Web of Science ®Google Scholar
• Wang X, Michoel A, Van den Mooter G. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm 2005;303:54–61.
   PubMed Web of Science ®Google Scholar
• Goddeeris C, Willems T, Houthoofd K, et al. Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100. Eur J Pharm Biopharm 2008;70:861–8.
   PubMed Web of Science ®Google Scholar
• Ghebremeskel AN, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer–surfactant combinations using solubility parameters and testing the processability. Int J Pharm 2007;328:119–29.
   PubMed Web of Science ®Google Scholar
• Shimpi MR, Childs SL, Boström D, et al. New cocrystals of ezetimibe with l-proline and imidazole. CrystEngComm 2014;16:8984–93.
   Web of Science ®Google Scholar
• Gulsun T, Gursoy RN, Oner L. Design and characterization of nanocrystal formulations containing ezetimibe. Chem Pharm Bull 2011;59:41–5.
   PubMed Web of Science ®Google Scholar
• Parmar KR, Shah SR, Sheth NR. Studies in dissolution enhancement of ezetimibe by solid dispersions in combination with a surface adsorbent. Dissolut Technol 2011;8:55–61.
   Google Scholar
• Taupitz T, Dressman JB, Klein S. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin. Eur J Pharm Biopharm 2013;84:208–18.
   PubMed Web of Science ®Google Scholar
• Paradkar A, Ambike AA Jadhav BK, et al. Characterization of curcumin–PVP solid dispersion obtained by spray drying. Int J Pharm 2004;271:281–6.
   PubMed Web of Science ®Google Scholar
• Fousteris E, Tarantili PA, Karavas E, et al. Poly (vinyl pyrrolidone)–poloxamer-188 solid dispersions prepared by hot melt extrusion. J Therm Anal Calorim 2013;113:1037–47.
   Web of Science ®Google Scholar
• Soliman S, Abdel Malak N, El Gazayerly O, et al. Preparation of celecoxib solid dispersions for dermal application: in vitro characterization and skin irritation test. J Drug Deliv Sci Technol 2011;21:509.
   Web of Science ®Google Scholar
• Patterson JE, James MB, Forster AH, et al. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. Int J Pharm 2007;336:22–34.
   PubMed Web of Science ®Google Scholar
• Ambike AA, Mahadik K, Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in vitro and in vivo evaluations. Pharm Res 2005;22:990–8.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Luo R, Chen Y, et al. Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion. AAPS PharmSciTech 2014;15:560–8.
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari KH, Li DX, et al. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm 2007;343:228–37.
   PubMed Web of Science ®Google Scholar
• Paoloni L, Patta A, Mangano F. The hydrogen bond with carbonyl groups: theoretical study of the correlation between the X–H stretching frequency shift and the C=O group proper. J Mol Struct 1975;27:123.
   Web of Science ®Google Scholar
• Mulye SP, Jamadar SA, Karekar PS, et al. Improvement in physicochemical properties of ezetimibe using a crystal engineering technique. Powder Technol 2012;222:131–8.
   Web of Science ®Google Scholar
• Matsumoto T, Zografi G. Physical properties of solid molecular dispersions of indomethacin with poly (vinylpyrrolidone) and poly (vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res 1999;16:1722–8.
   PubMed Web of Science ®Google Scholar
• Khougaz K, Clas S. Crystallization inhibition in solid dispersions of MK‐0591 and poly (vinylpyrrolidone) polymers. J Pharm Sci 2000;89:1325–34.
   PubMed Web of Science ®Google Scholar
• Gupta P, Bansal AK. Molecular interactions in celecoxib‐PVP‐meglumine amorphous system. J Pharm Pharmacol 2005;57:303–10.
   PubMed Web of Science ®Google Scholar
• Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14:1691–8.
   PubMed Web of Science ®Google Scholar
• Doherty C, York P. Evidence for solid‐ and liquid‐state interactions in a furosemide‐polyvinylpyrrolidone solid dispersion. J Pharm Sci 1987;76:731–7.
   PubMed Web of Science ®Google Scholar
• Carlert S, Pålsson A, Hanisch G, et al. Predicting intestinal precipitation—a case example for a basic BCS class II drug. Pharm Res 2010;27:2119–30.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–20.
   PubMed Web of Science ®Google Scholar
• Psachoulias D, Vertzoni M, Goumas K, et al. Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults. Pharm Res 2011;28:3145–58.
   PubMed Web of Science ®Google Scholar
• Konno H, Handa T, Alonzo DE, et al. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Eur J Pharm Biopharm 2008;70:493–9.
   PubMed Web of Science ®Google Scholar
• Lindfors L, Forssén S, Westergren J, et al. Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interface Sci 2008;325:404–13.
   PubMed Web of Science ®Google Scholar
• Warren DB, Benameur H, Porter CJ, et al. Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility. J Drug Target 2010;18:704–31.
   PubMed Web of Science ®Google Scholar
• Usui F, Maeda K, Kusai A, et al. Inhibitory effects of water-soluble polymers on precipitation of RS-8359. Int J Pharm 1997;154:59–66.
   Web of Science ®Google Scholar
• Bevernage J, Brouwers J, Brewster ME, et al. Evaluation of gastrointestinal drug supersaturation and precipitation: strategies and issues. Int J Pharm 2013;453:25–35.
   PubMed Web of Science ®Google Scholar
• Greco K, Bogner R. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing. Mol Pharm 2010;7:1406–18.
   PubMed Web of Science ®Google Scholar